Prevention of severe neonatal hyperbilirubinemia in healthy infants of 35 or more weeks of gestation: Implementation of a systems-based approach;Prevenção de hiperbilirrubinemia neonatal grave em lactentes saudáveis com 35 ou mais semanas de gestação: Implantação de uma abordagem sistemática

Jornal de Pediatria

Volumn 83, Issue 4, 2007, Pages 289-293

  Bhutani, Vinod K ^a   Johnson, Lois ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

BILIRUBIN BLOOD LEVEL; CEREBRAL PALSY; DELIVERY ROOM; EDITORIAL; GESTATIONAL AGE; HEALTH SERVICE; HUMAN; KERNICTERUS; NEUROLOGIC DISEASE; NEUROTOXICITY; NEWBORN JAUNDICE; PERCEPTION DEAFNESS; PHOTOTHERAPY; PROPHYLAXIS; RISK FACTOR;

HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; KERNICTERUS; PHOTOTHERAPY; POSTNATAL CARE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 34548274073     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1673     Document Type: Editorial

References (18)

1. Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr. 2002;140:396-403.
2. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297-316.
3. Bhutani VK, Johnson LH, Keren R. Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week. Pediatr Clin North Am. 2004;51:843-61,vii.
4. Bhutani VK, Johnson LH, Schwoebel A, Gennaro S. A systems approach for neonatal hyperbilirubinemia in term and near-term newborns. J Obstet Gynecol Neonatal Nurs. 2006;35:444-55.
5. Bhutani VK, Donn SM, Johnson LH. Risk management of severe neonatal hyperbilirubinemia to prevent kernicterus. Clin Perinatol. 2005;32:125-39.
6. Yeargin-Allsopp M. CDC Medical Officer Comment on "Prevent This" video for public education. http://www.cdc.gov/ncbddd/dd/kernicterus/ kernicterusvideos/kervideotransc.htm.
7. Lannon C, Stark AR. Closing the gap between guidelines and practice: ensuring safe and healthy beginnings. Pediatrics. 2004;114:494-6.
8. o F, Netto AA, Marba ST. Follow-up of neonatal jaundice in term and late premature newborns. J Pediatr (Rio J). 2007;83:313-8.
9. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. 2006;175:587-90.
10. Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154:1140-7.
11. Manning DJ, Maxwell MJ, Todd PJ, Platt MJ. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the United Kingdom and Ireland. Arch Dis Child Fetal Neonatal Ed. 2006; [Epub ahead of print]. http://fn.bmj.com/cgi/rapidpdf/adc.2006.105361v1.
12. Bhutani VK, Rodriguez M; HCA Perinatal Safety Initiative Kernicterus Taskforce. Recent epidemiologic indices of severe hyperbilirubinemia and kernicterus for a diverse multi-state newborn population in USA [abstract]. Presented as an abstract at the Pediatric Academic Society Annual Meeting; 2005.
13. Eggert LD, Wiedmeier SE, Wilson J, Christensen RD. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics. 2006;117:e855-62.
14. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr. 2000;89:1213-7.
15. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics.1999;103:6-14.
16. Stevenson DK, Fanaroff AA, Maisels MJ, Young BW, Wong RJ, Vreman HJ, et al. Prediction of hyperbilirubinemia in near term and term infants. Pediatrics. 2001;108:31-9.
17. Martinez JC, Garcia, HO, Otheguy LE, Drummond GS, Kappas A. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics. 1999;103:1-5.
18. Ebbesen F, Andersson C, Verder H, Grytter C, Pedersen-Bjergaard L, Petersen JR, et al. Extreme hyperbilirubinaemia in term and near-term infants in Denmark. Acta Paediatr. 2005;94:59-64.